Table 1 Study characteristics for studies assessing recovery of knee flexor strength symmetry
Author | Subgroups | Population size, n | Men/women | Age, mean ± SD (range) | Autograft | Timepoint of assessments (months) |
|---|---|---|---|---|---|---|
Araki et al. 2011 [24] | SB | 10 | 5/5 | 24.7 ± 11.8 | STG | 12 ± 2.3 |
DB | 10 | 5/5 | 25.2 ± 12.1 | 13.5 ± 3.2 | ||
Baba et al. 2019 [25] | Surgery < 1 months | 25 | 13/12 | 28.0 ± 11.5 | ST | Preop, 24 |
Surgery 1–3 months | 72 | 38/34 | 26.4 ± 11.3 | |||
Surgery > 3 months | 74 | 48/26 | 27.5 ± 13.7 | |||
Barenius et al. 2013 [26] | STG | 10 | 8/2 | 26 ± 9 | STG | 37 ± 6 |
ST | 10 | 8/2 | 26 ± 7 | ST | 36 ± 4 | |
Beaudoin et al. 2022 [27] | Ipsilateral graft | 20 | 14/6 | 41.6 ± 12.4 | STG | 153.6 ± 20.4 |
Blucher et al. 2022 [28] | NA | 210 | 100/110 | 17 (10–19) | STG | 12 |
Carter and Edinger 1999 [29] | ST | 33 | Missing | Missing | ST | 6 (6–7) |
STG | 35 | Missing | Missing | STG | ||
Chantrelle et al. 2023 [30] | No anterior knee pain | 281 | 199/82 | 25.8 ± 6.8 | HT | 4, 7 |
Chen et al. 2010 [31] | NA | 312 | 209/103 | 25 (18–57) | STG | Preop, 55 |
Chen et al. 2004 [32] | NA | 62 | 39/23 | 24 (18–52) | STG | Preop, 28 |
Cristiani et al. 2019 [33] | HT group | 3788 | Missing | Missing | HT | 6 |
Ebert et al. 2019 [34] | NA | 50 | 32/18 | 26.3 ± 9.6 (16–49) | STG | 12, 24 |
Ebert et al. 2021 [35] | DB HT graft | 69 | 44/25 | 30.8 ± 10.6 (16–49) | STG | 92.4 ± 7.2 (84–114) |
DB HT graft + LARS | 67 | 45/22 | 31.1 ± 9.3 (16–49) | 94.8 ± 10.8 (84–120) | ||
Ebert et al. 2021 [36] | NA | 25 | 17/8 | 25.4 ± 8.9 | ST | 10.8 ± 1.4 (9–12) |
Ebert et al. 2022 [37] | Accelerated | 22 | 12/10 | 24.9 ± 7.1 (16–41) | STG | 6, 9, 12, 24 |
Control | 22 | 12/10 | 25.7 ± 7.9 (16–42) | |||
Fabbriciani et al. 2005 [38] | NA | 18 | 18/0 | 27.4 (17–40) | STG | 6, 24 |
Fischer et al. 2018 [39] | NA | 63 | 47/16 | 21.5 ± 6.9 (11–41) | HT | 5.4 ± 1.3, 7.5 ± 1.8 |
Gifstad et al. 2013 [40] | EzLoc | 55 | 36/19 | 24 (18–45) | STG | 24 |
Bone Mulch | 55 | 35/20 | 27 (18–45) | |||
Guney-Deniz et al. 2020 [41] | HT group | 24 | 18/4 | 26.7 ± 4.6 | HT | 13.3 ± 1.8 |
Hamada et al. 2001 [42] | Single-socket | 57 | 26/31 | 25 ± 8.5 | HT | 26.7 ± 3.5 |
Bi-socket | 49 | 23/26 | 24 ± 8.2 | |||
Hanada et al. 2019 [43] | HT group | 32 | 17/15 | 31 (14–60) | STG | Preop, 6, 12 |
Harilainen et al. 2005 [44] | Transfix | 31 | 19/12 | 27 (15–56) | STG | 12, 24 |
Interference screw | 31 | 23/8 | 32 (18–49) | ST | ||
Harilainen et al. 2006 [45] | HT group | 48 | Missing | Missing | STG | 60 (47–79) |
Harput et al. 2018 [46] | NA | 72 | 72/0 | 28.0 ± 7.6 | STG | 6 |
Hasebe et al. 2005 [47] | NA | 15 | 8/7 | 22 ± 4.1 | STG | Preop, 27.5 ± 2.5 |
Holm et al. 2010 [48] | HT group | 29 | 15/14 | 27 ± 9 | STG | 120 |
Högberg et al. 2022 [49] | NA | 127 | 70/57 | 24.9 ± 8.1 | HT | 2.5, 4, 8, 12 |
Inagaki et al. 2013 [50] | ST | 61 | 35/26 | 28.2 ± 11.9 | ST | 24 |
STG | 59 | 33/26 | 26.2 ± 10.3 | STG | ||
Iriuchishima et al. 2010 [51] | Standard | 14 | 9/5 | 28.2 ± 7.6 | HT | 3, 6, 9 |
Accelerated | 20 | 12/8 | 23.2 ± 4.5 | |||
Johnston et al. 2022 [52] | HT group | 70 | 54/16 | 20.0 ± 9.0 | STG | 6, 12 |
Karlson et al. 1994 [53] | OTT | 32 | 19/13 | 26.9 ± 7.2 | STG | 39.6 ± 8.4 |
TCC | 32 | 23/9 | 28.0 ± 9.0 | 28.8 ± 3.6 | ||
Kılınç et al. 2015 [54] | NA | 55 | 54/1 | 28.18 ± 6.21 (17–40) | HT | 23.09 ± 9.08 (9–42) |
Koga et al. 2015 [55] | 0° | 25 | 18/7 | 24.6 (14–52) | ST | 24 |
20° | 26 | 14/12 | 26.2 (13–63) | |||
45° | 24 | 14/10 | 22.4 (14–42) | |||
Koga et al. 2015 [56] | SB | 25 | 7/18 | 24 (14–44) | ST | 71 (36–140) |
DB | 28 | 16/12 | 25 (14–49) | 68 (36–136) | ||
Kondo et al. 2012 [57] | ECL | 23 | 12/11 | 24 (15–45) | STG | 24 |
ECL-BTB | 23 | 13/10 | 25 (15–45) | |||
Kondo et al. 2016 [58] | 40° tension | 44 | 30/14 | 27 (14–57) | HT | 29 (24–72) |
30° tension | 53 | 31/22 | 26 (15–50) | |||
Kouloumentas et al. 2019 [59] | ST | 45 | 28/17 | 27.6 ± 11.4 | ST | 24 |
STG | 45 | 27/18 | 29.7 ± 11.0 | STG | ||
Koutras et al. 2013 [60] | Anteromedial portal | 15 | 15/0 | 21.5 ± 4 | HT | 3, 6 |
Transtibial portal | 36 | 26/0 | 24.9 ± 6 | |||
Królikowska et al. 2019 [61] | Supervised < 6 months | 77 | 77/0 | 29.3 ± 7.4 | STG | 6.8 ± 1.5 |
Supervised > 6 months | 66 | 66/0 | 29.4 ± 9.0 | |||
Królikowska et al. 2018 [62] | Supervised > 6 months | 18 | 18/0 | 25.1 ± 5.6 | STG | 6.9 ± 1.5, 7.8 ± 2.1 |
Lautamies et al. 2008 [63] | HT group | 113 | 65/48 | 29 (13–56) | STG | 60 |
Lee et al. 2015 [64] | NA | 20 | 15/5 | 30.5 (17–51) | STG | Preop, 6, 12 |
Lee et al. 2016 [65] | HT group | 48 | 44/4 | 29.9 (17–58) | STG | 12, 24 |
Lesevic et al. 2020 [66] | HT group | 66 | 34/32 | Missing | HT | 6 |
Maeda et al. 1996 [67] | NA | 41 | 22/19 | 24 (16–41) | ST | 27 (24–42) |
Matsumoto et al. 2006 [68] | HT group | 35 | 15/20 | 24.4 ± 9.7 | STG | 80.7 ± 13.2 |
Murray et al. 2019 [69] | NA | 10 | 2/8 | 24.6 ± 5.5 | STG | 6, 12, 24 |
Nakamura et al. 2002 [70] | ST | 49 | 28/21 | 24.3 | ST | 24 |
STG | 25 | 6/19 | 25.7 | STG | ||
Nishio et al. 2018 [71] | > 40 years old | 40 | 17/43 | 48 (40–71) | ST | 24 |
< 40 years old | 56 | 31/25 | 38 (20–39) | |||
Ogborn et al. 2021 [72] | NA | 31 | 18/13 | 44.2 ± 10.7 | ST | 168 ± 52.8 |
Riesterer et al. 2020 [73] | NA | 80 | 54/26 | 29.9 ± 9 | ST | Preop, 6 |
Roman et al. 2021 [74] | Adolescents (15–17 years) | 89 | 42/47 | 16.3 ± 0.8 | HT | 7.6 ± 1.5 |
Sanada et al. 2021 [75] | HT group | 29 | 29/0 | 16.5 (12–20) | HT | 5, 8, 12 |
San Jose et al. 2022 [76] | Early rehabilitation | 89 | 51/38 | 21 (18–25) | HT | 4 (4–5) |
Late rehabilitation | 42 | Missing | 20 (18–25) | 10 (9–11) | ||
Sengoku et al. 2022 [77] | ST | 41 | 21/20 | 21.7 ± 9.2 | ST | 3, 6 |
STG | 41 | 21/20 | 19.6 ± 7.0 | STG | ||
Severyns et al. 2022 [78] | No graft failure | 93 | 62/31 | 26.5 ± 9 | ST | 6 |
Graft failure | 11 | 7/4 | 22.7 ± 6.1 | |||
Sinding et al. 2020 [79] | HT group | 43 | 23/20 | 28.3 ± 6.2 | STG | 12 |
Suh et al. 2021 [80] | Dominant leg | 58 | 40/18 | 29.5 ± 9.1 | HT | Preop, 6, 12 |
Non-dominant leg | 42 | 32/10 | 28.8 ± 9.1 | |||
Tajima et al. 2021 [81] | HT group | 43 | 40/3 | 24.8 ± 7.3 | STG | 12 |
Taketomi et al. 2018 [82] | HT group | 23 | 6/17 | 32 (15–55) | HT | 12 |
Tanaka et al. 2010 [83] | NA | 64 | 64/0 | 16.2 (12–29) | ST | Preop, 6 |
Tim-Yun Ong et al. 2022 [84] | NA | 16 | 8/8 | 25.7 ± 6 | HT | 6–9 |
Tsuda et al. 2009 [85] | Women | 50 | 0/50 | 23 ± 9 (13–47) | STG | Preop, 3, 6, 12, 18, 37 |
Men | 32 | 32/0 | 26 ± 10 (14–44) | |||
Ueda et al. 2021 [86] | NA | 97 | 51/46 | 21.7 ± 8.5 | HT | 12.2 ± 1 (11–16) |
Witvrouw et al. 2001 [87] | HT group | 32 | 17/15 | 24.6 (17–34) | STG | Preop, 6, 12 |